{"id":"W4399119041","doi":"10.1016/s2468-1253(24)00095-5","title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","year":2024,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"AstraZeneca United States","keywords":"Gemcitabine; Durvalumab; Interim analysis; Cisplatin; Placebo; Topaz; Interim; Medicine; Internal medicine; Oncology; Biliary tract cancer; Cancer; Clinical trial; Chemotherapy; Biology; Pathology; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005939815,0.0005100737,0.001930973,0.0002138629,0.0001270896,0.00003809947,0.0002327228,0.0001496071,0.0002599693],"category_scores_gemma":[0.00005023969,0.0003150034,0.0001116394,0.0002635931,0.0004351438,0.000129938,0.0001601591,0.0007994042,0.00001080192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002073683,"about_ca_system_score_gemma":0.0002680513,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00133845,"about_ca_topic_score_gemma":0.03190319,"domain_scores_codex":[0.9962031,0.000674492,0.0007295064,0.000995589,0.0002716824,0.001125593],"domain_scores_gemma":[0.9984617,0.0005327175,0.0001597238,0.0005786324,0.00007446144,0.0001928184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1835112,0.0006657472,0.8057365,0.00007233609,0.001111528,0.003040512,0.002561315,0.00003128144,0.0007130089,0.000004166306,0.001054416,0.001497933],"study_design_scores_gemma":[0.2389277,0.006114453,0.7441155,0.0001868554,0.001258273,0.0005521455,0.001157002,0.006400722,0.00004476959,0.00003793386,0.0009200196,0.0002846188],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886989,0.002737891,0.000111805,0.005257255,0.0006873465,0.002112634,0.0001720664,0.0001523236,0.00006975889],"genre_scores_gemma":[0.9958976,0.000472927,0.0001127679,0.00185517,0.0003760128,0.001013366,0.00008794147,0.00006314349,0.0001210998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06162101,"threshold_uncertainty_score":0.9999302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04131311166689571,"score_gpt":0.3340527491027465,"score_spread":0.2927396374358508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}